12-31-2022: Atlanta, GA: Shuiyun Lan's "Paxlovid will eventually lose most of its efficacy" study has been upgraded [or downgraded?] into the NIH format: https://t.co/xeKmCu20Vx https://t.co/u170ip2Xkj https://t.co/xdyHEZHbGN https://t.co/ceUjpkiWi7 https
137 followers
137 followers
7-7-22: Haein Kim's seemingly pro-Paxlovid study is really anti-Paxlovid. Unlike vaccines & antibody drugs, antivirals should not lose efficacy after spike protein mutations. Drug resistance against Paxlovid developed very rapidly between BA.1 and B
632 followers
Can nirmatrelvir/ritonavir treatment shorten the duration of COVID-19 isolation? https://t.co/N16ttQJ9ow